IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IRLAB Therapeutics AB
Free Cash Flow Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Free Cash Flow
-kr165.1m
CAGR 3-Years
-23%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Free Cash Flow
-kr244.9m
CAGR 3-Years
21%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Free Cash Flow
kr643.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Free Cash Flow
kr351m
CAGR 3-Years
67%
CAGR 5-Years
72%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Free Cash Flow
-kr33.2m
CAGR 3-Years
-29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Free Cash Flow
-kr113.9m
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Free Cash Flow?
Free Cash Flow
-165.1m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Free Cash Flow amounts to -165.1m SEK.

What is IRLAB Therapeutics AB's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-18%

Over the last year, the Free Cash Flow growth was -14%. The average annual Free Cash Flow growth rates for IRLAB Therapeutics AB have been -23% over the past three years , -18% over the past five years .

Back to Top